{"symbol":"BSX","fiscalQuarter":"Q1-2021","reportDate":"2021-04-28","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q1-2021","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Up 4.32%","keyNumbers":[{"metric":"EPS","actual":"$0.37","expected":"N/A","surprise":"+22.11%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed satisfaction with the EPS performance despite not providing revenue figures.","They highlighted ongoing efforts to navigate market challenges.","The focus remains on innovation and expanding product offerings."],"summary":"Management conveyed a cautiously optimistic outlook, emphasizing their commitment to growth. They acknowledged market challenges but remain focused on innovation."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's strong EPS performance, beating expectations by over 22%, led to a positive stock reaction, with shares rising 4.32%. The absence of revenue figures leaves some uncertainty, but management's focus on innovation suggests a commitment to long-term growth. Investors may view the earnings beat as a sign of resilience in a challenging market environment.","metaDescription":"Boston Scientific (BSX) Q1 2021 earnings: EPS beat by 22.11%. Stock up 4.32%. Full breakdown."}}